Jeffrey E. Russel

Array ( [id] => 7208626 [patent_doc_number] => 20050053594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK' [patent_app_type] => utility [patent_app_number] => 10/823433 [patent_app_country] => US [patent_app_date] => 2004-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 31767 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053594.pdf [firstpage_image] =>[orig_patent_app_number] => 10823433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7297223 [patent_doc_number] => 20040214775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein' [patent_app_type] => new [patent_app_number] => 10/820983 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7159 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214775.pdf [firstpage_image] =>[orig_patent_app_number] => 10820983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859793 [patent_doc_number] => 20060229255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Identification of n-alkylglycine trimers for induction of apoptosis' [patent_app_type] => utility [patent_app_number] => 10/553285 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7696 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229255.pdf [firstpage_image] =>[orig_patent_app_number] => 10553285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083807 [patent_doc_number] => 20050049187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Process for preparing macrocyclic compounds' [patent_app_type] => utility [patent_app_number] => 10/818657 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7039 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049187.pdf [firstpage_image] =>[orig_patent_app_number] => 10818657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 558260 [patent_doc_number] => 07157422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'Glycogen synthase kinase-3 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/810578 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 21462 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157422.pdf [firstpage_image] =>[orig_patent_app_number] => 10810578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 623779 [patent_doc_number] => 07138487 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-21 [patent_title] => 'Extractive purification of lipopeptide antibiotics' [patent_app_type] => utility [patent_app_number] => 10/810741 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7500 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/138/07138487.pdf [firstpage_image] =>[orig_patent_app_number] => 10810741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672948 [patent_doc_number] => 20040180831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same' [patent_app_type] => new [patent_app_number] => 10/806523 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 36546 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180831.pdf [firstpage_image] =>[orig_patent_app_number] => 10806523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 727497 [patent_doc_number] => RE039086 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2006-05-02 [patent_title] => 'Cosmetic use of botulinum toxin for treatment of downturned mouth' [patent_app_type] => reissue [patent_app_number] => 10/802381 [patent_app_country] => US [patent_app_date] => 2004-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2186 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039086.pdf [firstpage_image] =>[orig_patent_app_number] => 10802381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 494010 [patent_doc_number] => 07211565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-01 [patent_title] => 'Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders' [patent_app_type] => utility [patent_app_number] => 10/801897 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 36115 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211565.pdf [firstpage_image] =>[orig_patent_app_number] => 10801897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 849185 [patent_doc_number] => 07381703 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-03 [patent_title] => 'Aplidine for multiple myeloma treatment' [patent_app_type] => utility [patent_app_number] => 10/548710 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 4621 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381703.pdf [firstpage_image] =>[orig_patent_app_number] => 10548710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 849185 [patent_doc_number] => 07381703 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-03 [patent_title] => 'Aplidine for multiple myeloma treatment' [patent_app_type] => utility [patent_app_number] => 10/548710 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 4621 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381703.pdf [firstpage_image] =>[orig_patent_app_number] => 10548710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7433868 [patent_doc_number] => 20040266663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and bruch\'s membrane (BM)' [patent_app_type] => new [patent_app_number] => 10/794198 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17312 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266663.pdf [firstpage_image] =>[orig_patent_app_number] => 10794198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 456599 [patent_doc_number] => 07244703 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-17 [patent_title] => 'Pharmaceutical compositions and methods for peptide treatment' [patent_app_type] => utility [patent_app_number] => 10/895465 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6001 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/244/07244703.pdf [firstpage_image] =>[orig_patent_app_number] => 10895465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7409785 [patent_doc_number] => 20040176307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Method of regulating glucose metabolism, and reagents related thereto' [patent_app_type] => new [patent_app_number] => 10/794316 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19321 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176307.pdf [firstpage_image] =>[orig_patent_app_number] => 10794316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978504 [patent_doc_number] => 20050288222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Methods for enhancing the bioavailability of a drug' [patent_app_type] => utility [patent_app_number] => 10/793388 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21765 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288222.pdf [firstpage_image] =>[orig_patent_app_number] => 10793388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467980 [patent_doc_number] => 20040167063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Novel cyclosporin galenic forms' [patent_app_type] => new [patent_app_number] => 10/790543 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14380 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167063.pdf [firstpage_image] =>[orig_patent_app_number] => 10790543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 517098 [patent_doc_number] => 07193038 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-20 [patent_title] => 'Extraction and utilization of cell growth-promoting peptides from silk protein' [patent_app_type] => utility [patent_app_number] => 10/789494 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12576 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/193/07193038.pdf [firstpage_image] =>[orig_patent_app_number] => 10789494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7333315 [patent_doc_number] => 20040131626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (tb4) analogues, isoforms and other derivatives' [patent_app_type] => new [patent_app_number] => 10/471621 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3076 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131626.pdf [firstpage_image] =>[orig_patent_app_number] => 10471621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 671812 [patent_doc_number] => 07090846 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-15 [patent_title] => 'Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body' [patent_app_type] => utility [patent_app_number] => 10/782962 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9115 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/090/07090846.pdf [firstpage_image] =>[orig_patent_app_number] => 10782962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434126 [patent_doc_number] => 20040162388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Activated polyethylene glycol esters' [patent_app_type] => new [patent_app_number] => 10/782268 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6026 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162388.pdf [firstpage_image] =>[orig_patent_app_number] => 10782268 [rel_patent_id] =>[rel_patent_doc_number] =>)